Globus Medical Debt to Equity Ratio 2010-2022 | GMED
Current and historical debt to equity ratio values for Globus Medical (GMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Globus Medical debt/equity for the three months ending September 30, 2022 was 0.00.
| Globus Medical Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2022-09-30 |
$0.21B |
$1.76B |
0.12 |
| 2022-06-30 |
$0.22B |
$1.70B |
0.13 |
| 2022-03-31 |
$0.21B |
$1.79B |
0.12 |
| 2021-12-31 |
$0.22B |
$1.74B |
0.12 |
| 2021-09-30 |
$0.19B |
$1.72B |
0.11 |
| 2021-06-30 |
$0.19B |
$1.64B |
0.12 |
| 2021-03-31 |
$0.18B |
$1.56B |
0.11 |
| 2020-12-31 |
$0.17B |
$1.51B |
0.12 |
| 2020-09-30 |
$0.13B |
$1.42B |
0.09 |
| 2020-06-30 |
$0.13B |
$1.34B |
0.10 |
| 2020-03-31 |
$0.12B |
$1.36B |
0.09 |
| 2019-12-31 |
$0.13B |
$1.40B |
0.09 |
| 2019-09-30 |
$0.11B |
$1.34B |
0.09 |
| 2019-06-30 |
$0.10B |
$1.29B |
0.08 |
| 2019-03-31 |
$0.10B |
$1.24B |
0.08 |
| 2018-12-31 |
$0.12B |
$1.19B |
0.10 |
| 2018-09-30 |
$0.10B |
$1.14B |
0.09 |
| 2018-06-30 |
$0.10B |
$1.10B |
0.09 |
| 2018-03-31 |
$0.10B |
$1.03B |
0.10 |
| 2017-12-31 |
$0.11B |
$0.97B |
0.11 |
| 2017-09-30 |
$0.10B |
$0.94B |
0.11 |
| 2017-06-30 |
$0.09B |
$0.91B |
0.10 |
| 2017-03-31 |
$0.09B |
$0.87B |
0.11 |
| 2016-12-31 |
$0.10B |
$0.83B |
0.12 |
| 2016-09-30 |
$0.09B |
$0.81B |
0.11 |
| 2016-06-30 |
$0.09B |
$0.78B |
0.12 |
| 2016-03-31 |
$0.09B |
$0.75B |
0.12 |
| 2015-12-31 |
$0.12B |
$0.72B |
0.17 |
| 2015-09-30 |
$0.13B |
$0.67B |
0.19 |
| 2015-06-30 |
$0.12B |
$0.64B |
0.19 |
| 2015-03-31 |
$0.13B |
$0.61B |
0.21 |
| 2014-12-31 |
$0.12B |
$0.59B |
0.20 |
| 2014-09-30 |
$0.09B |
$0.55B |
0.17 |
| 2014-06-30 |
$0.09B |
$0.53B |
0.17 |
| 2014-03-31 |
$0.10B |
$0.50B |
0.19 |
| 2013-12-31 |
$0.09B |
$0.47B |
0.20 |
| 2013-09-30 |
$0.08B |
$0.45B |
0.17 |
| 2013-06-30 |
$0.08B |
$0.42B |
0.18 |
| 2013-03-31 |
$0.07B |
$0.41B |
0.16 |
| 2012-12-31 |
$0.06B |
$0.39B |
0.16 |
| 2012-09-30 |
$0.05B |
$0.36B |
0.14 |
| 2012-06-30 |
$0.05B |
$0.32B |
0.14 |
| 2012-03-31 |
$0.05B |
$0.30B |
0.18 |
| 2011-12-31 |
$0.05B |
$0.28B |
0.17 |
| 2011-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2011-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2010-12-31 |
$0.04B |
$0.23B |
0.17 |
| 2009-12-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$7.483B |
$0.958B |
|
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
|
